Study of the mechanisms of impaired beta-receptor responsiveness in arterial hypertension
Volpe, M.; Ricciardelli, B.; De Luca, N.; Picotti, G.B.; Cuocolo, A.; Veniero, A.M.; De Simone, A.; Trimarco, B.; Condorelli, M.
Cardiologia 28(6): 513-522
1983
ISSN/ISBN: 0393-1978 PMID: 6331471 Document Number: 212403
Document emailed within 1 workday
Related Documents
Savenkov, P.M.; Doshitsin, V.L.; Grudtsyn, G.V. 1977: Use of the adrenergic beta receptor blockader, visken, (prindolol) in arterial hypertension Kardiologiia 17(10): 62-66Inouye, K.; Chan, O.; Riddell, M.C.; Akirav, E.; Matthews, S.G.; Vranic, M. 2002: Mechanisms of impaired hypothalamic-pituitary-adrenal (HPA) function in diabetes: reduced counterregulatory responsiveness to hypoglycaemia Diabetes Nutrition and Metabolism 15(5): 348-355; Discussion: 355-356, 362
Cybulska, I.; Sznajderman, M.; Brym, E.; Czerniewska, E. 1981: Own experience with labetalol - a new adrenergic alpha and beta receptor blockader - in the treatment of arterial hypertension Polski Tygodnik Lekarski 36(34): 1309-1311
Dück, K.; Strube, G.; Knappe, J. 1976: Therapy of chronic ischemic heart disease and arterial hypertension by means of beta-receptor blockaders Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 31(3): 324-327
Hamelin, B.A.; Blouin, R.A.; Wolf, K.M.; Clifton, G.D.; Chandler, M.H. 1992: In vivo and in vitro beta 2-adrenergic receptor responsiveness in young and elderly asthmatics PharmacoTherapy 12(5): 376-382
Kahan, T.; Hjemdahl, P.; Lindvall, K.; Ostergren, J.; de Faire, U. 1998: Adrenaline responsiveness in mild hypertension: no evidence for altered beta-adrenoceptor sensitivity Journal of Cardiovascular Pharmacology 32(5): 753-759
Rostan, A. 1978: Effects of tolamolol and bufuralol on the arterial blood pressure and plasma renin activity. Contribution to the study of beta-blocking agents action mechanisms Schweizerische Rundschau für Medizin Praxis 67(1): 27-35
Hoffmann, J.; Schrey, A.; Grund, R.; Forst, T. 1981: Combination of beta-receptor blocking agents and saluretica in outpatient treatment of hypertension. Results of a comparative study Münchener Medizinische Wochenschrift 123(12): 483-488
Mohallen, K.L.; do Patrocínio, L.L.; Célnik, D.; Kruczan, D.D.; Pinheiro, L.; Weitzel, L.H.; Bosco, J.; Sekeff, J.A.; Azevedo, A.d.C. 1987: Normalization of ventricular compliance and hypertrophy in arterial hypertension. Double-blind study with 2 combinations of a beta blocker and diuretic Arquivos Brasileiros de Cardiologia 48(6): 345-350
Metelitsa, V.I.; Filatova, N.P. 1990: Role of a beta adrenergic blocking agent nadolol (corgard) in prevention of arterial hypertension: a 6-month treatment (cooperative study) Kardiologiia 30(5): 8-14
Forette, F.; Henry-Amar, M.; d'Allens, H.; Hervy, M.P.; Bouchacourt, P.; Henry, J.F.; Pappo, M. 1987: Arterial hypertension in the elderly. Double-blind study versus placebo of the efficacy and tolerability of an alpha-beta blocker: labetalol Annales de Cardiologie et d'Angeiologie 36(2): 103-107
Zilenovski, A.M.; Freire, C.A.; Iverson, M.T. 1984: Evaluation of the therapeutic efficacy of a fixed combination of beta blockader and diuretic, in the treatment of systemic arterial hypertension. a multicenter study Arquivos Brasileiros de Cardiologia 42(6): 435-441
Planz, G.; Planz, R.; Gierlichs, H.W.; Rahn, K.H. 1978: Effect of the beta-receptor blocker propranolol on the catecholamin level and dopamin-beta-hydroxylase in patients with essential hypertension Die Medizinische Welt 29(9): 366-367
Simonenko, V.B.; Medvedev, I.N.; Gamolina, O.V. 2011: Primary hemostasis activity in patients with arterial hypertension and impaired glucose tolerance treated with trandolapril Klinicheskaia Meditsina 89(2): 29-31
Mey, J.; Grünwald, J.; Hauss, W.H. 1980: Growth rate differences between arterial smooth muscle cells cultivated from rat impaired by short--or long--term hypertension respectively Artery 8(4): 348-354
Tokar', A.V.; Ena, L.M.; Rudaia, E.S.; Shmidt, A.D. 1980: Mechanisms of development of arterial hypertension in old age Vestnik Akademii Meditsinskikh Nauk SSSR 3: 57-64
Sakatsume, M.; Finbloom, D.S. 1996: Modulation of the expression of the IFN-gamma receptor beta-chain controls responsiveness to IFN-gamma in human peripheral blood T cells Journal of Immunology 156(11): 4160-4166
Metelitsa, V.I.; Filatova, N.P. 1991: The results of the comparative study of nadolol, propranolol, prazosin and hydrochlorothiazide in patients with arterial hypertension in a 12-month stepped-plan treatment (cooperative research). The Working Group of the Cooperative Program to Study New Preparations in the Prevention of Arterial Hypertension. I. The research protocol and results of monotherapy Terapevticheskii Arkhiv 63(8): 30-34
Batyraliev, T.A.; Makhmutkhodzhaev, S.A.; Ekinsi, E.; Pataraia, S.A.; Pershukov, I.V.; Sidorenko, B.A.; Preobrazhenskiĭ, D.V. 2007: Pulmonary hypertension and right ventricular failure. Part XI. Endothelin receptor blockers in the treatment of primary pulmonary arterial hypertension Kardiologiia 47(7): 73-82
Ohtsuka, K.; Yasunami, Y.; Ikehara, Y.; Nagai, T.; Kodama, S.; Maki, T.; Tomita, A.; Abo, T.; Ikeda, S. 1997: Expansion of intermediate T cell receptor cells expressing interleukin-2 receptor alpha- beta+, CD8alpha+ beta+, and lymphocyte function-associated antigen-1+ in the liver in association with intrahepatic islet xenograft rejection from rat to mouse: prevention of rejection with anti-interleukin-2 receptor beta monoclonal antibody treatment Transplantation 64(4): 633-639